Tang Capital Management’s Journey Medical DERM Stock Holding History

Tang Capital Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.55M	Sell	1,610,000 -244,596	-13%	-$1.9M	0.38%	30
2025 Q4	$14.3M	Hold	1,854,596	–	–	0.71%	32
2025 Q3	$13.2M	Hold	1,854,596	–	–	0.51%	49
2025 Q2	$13.3M	Hold	1,854,596	–	–	0.67%	42
2025 Q1	$10.9M	Buy	1,854,596 +129,027	+7%	+$634K	0.61%	44
2024 Q4	$6.75M	Buy	+1,725,569	New	+$9.43M	0.45%	62
2024 Q3	–	Sell	-148,322	Closed	-$837K	–	158
2024 Q2	$837K	Buy	148,322 +9,697	+7%	+$39.9K	0.09%	98
2024 Q1	$510K	Buy	+138,625	New	+$603K	0.05%	94
2023 Q4	–	Sell	-576,100	Closed	-$1.58M	–	126
2023 Q3	$1.58M	Buy	+576,100	New	+$1.29M	0.22%	77

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Tang Capital Management's DERM Position: Q1 2026 in Review

Tang Capital Management reduced its Journey Medical (DERM) stake by 13% in Q1 2026, selling an estimated $1.9M and leaving 1,610,000 shares worth $7.55M. The position accounts for 0.38% of the portfolio, ranked #30.

Tang Capital Management first reported a position in DERM in Q3 2023 and has held it in 9 quarters since. The position peaked at $14.3M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

Tang Capital Management held 1,610,000 shares of Journey Medical worth $7.55M as of Q1 2026.
Tang Capital Management sold 244,596 Journey Medical shares in Q1 2026, an estimated $1.9M.
Journey Medical made up 0.38% of Tang Capital Management's portfolio in Q1 2026, its #30 holding.
Tang Capital Management first reported a position in Journey Medical in Q3 2023 and has held it in 9 quarters since.
Tang Capital Management's Journey Medical position peaked at $14.3M in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.